Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the efficacy and safety of NALIRINOX combined with PD-1 synchronous sequential SBRT or AG combined with PD-1 synchronous sequential SBRT as first line systemati...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Du Juan
NCT07438106 · Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
NCT03652428 · Locally Advanced Pancreatic Cancer
NCT05975593 · Locally Advanced Cervical Carcinoma, Locally Advanced Cervical Cancer, and more
NCT07429643 · Locally Advanced Pancreatic Cancer
NCT06378047 · Pancreatic Cancer, Locally Advanced Pancreatic Cancer
FirstNanjingMU
Nanjing, Jiangsu
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions